Journal of Gastroenterology

Papers
(The TQCC of Journal of Gastroenterology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Managing radiation safety and protection in gastroenterology in Japan: insights from the REX-GI study252
Utility of a new automated diagnostic program in high-resolution esophageal manometry183
Ratio of submucosal thickness to total bowel wall thickness as a new sonographic parameter to estimate endoscopic remission of ulcerative colitis142
Corynoline protects chronic pancreatitis via binding to PSMA2 and alleviating pancreatic fibrosis97
Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom85
Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: a retrospectiv78
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy66
Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus57
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma55
Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers49
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy45
Correlation between mismatch repair and survival of patients with gastric cancer after 5-FU-based adjuvant chemotherapy45
Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease44
Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism44
Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts39
Novel subharmonic-aided pressure estimation for identifying high-risk esophagogastric varices38
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis38
Clinical practice guidelines for duodenal cancer 202137
STING and liver disease34
Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database31
Successful induction of human chemically induced liver progenitors with small molecules from damaged liver29
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials28
Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial26
Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data26
Predictive factors for the progression of primary localized stage small-bowel follicular lymphoma26
Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan26
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy25
What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?24
Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan24
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis24
The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery24
Persistent body-weight change on achalasia and peroral endoscopic myotomy: a multicenter cohort study24
Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 202123
Correction: Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis23
Acknowledgements23
Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation22
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey22
Evaluation of cholecystectomy in older individuals using real-world data: a multilevel analysis based on a nationwide administrative database in Japan22
Expert consensus on vaccination in patients with inflammatory bowel disease in Japan22
A study for every second day administration of vonoprazan for maintenance treatment of erosive GERD (ESD von GERD): a multicenter randomized cross-over study20
Nationwide cohort study identifies clinical outcomes of angioectasia in patients with acute hematochezia19
Is it necessary for endoscopic surveillance for achalasia patients?19
Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study19
Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials18
Targeting autophagy as a therapeutic strategy against pancreatic cancer18
Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinoma18
Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study18
Utility of artificial intelligence with deep learning of hematoxylin and eosin-stained whole slide images to predict lymph node metastasis in T1 colorectal cancer using endoscopically resected specime18
Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)18
“Pathologist-independent” strategy for T1 colorectal cancer after endoscopic resection17
Reply to “Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data”17
Gastric cancer and genomics: review of literature17
RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer17
Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases17
Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-1917
Physician–patient communication affects patient satisfaction in treatment decision-making: a structural equation modelling analysis of a web-based survey in patients with ulcerative colitis16
Impact of ursodeoxycholic acid treatment on Fontan-associated liver disease16
Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL)16
Cancer pathways in serrated polyposis syndrome: is conventional more crucial than serrated?15
Correction: Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multic15
Reply to “promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy”15
Frequency of lymph node metastasis according to tumor location in clinical T1 early gastric cancer: supplementary analysis of the Japan Clinical Oncology Group study (JCOG0912)15
Effect of blood product transfusion on the prognosis of patients undergoing hepatectomy for hepatocellular carcinoma: a propensity score matching analysis14
Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society14
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation14
Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance14
Identification of novel plasma proteins as promising noninvasive biomarker for early diagnosis and surveillance of pancreatic ductal adenocarcinoma14
Characteristics, outcomes, and risk factors of surgery for acute lower gastrointestinal bleeding: nationwide cohort study of 10,342 hematochezia cases14
The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry14
The role of stromal BMP/CXCL12 signaling axis in serrated polyp development13
Prevalence of colonoscopy in Japan using a large-scale health claims data compared to esophagogastroduodenoscopy13
Risk of gastric and oesophageal adenocarcinomas following discontinuation of long-term proton-pump inhibitor therapy13
HBeAg-positive patients with HBsAg  < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation13
Novel scale for evaluating the therapeutic efficacy of per-oral endoscopic myotomy in achalasia12
Correction: Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer12
Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY12
Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearance12
Renal manifestations in inflammatory bowel disease: a systematic review12
Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy12
Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation12
Correction to: Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia12
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study11
Publisher Correction: Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study11
The external validation of Dallas Steatosis Index among Asian population: a useful tool for metabolic dysfunction-associated steatotic liver disease identification and prevention11
Efficacy, tolerability, and safety of oral sulfate tablet versus 2 L-polyethylene glycol/ascorbate for bowel preparation in older patients: prospective, multicenter, investigator single-blinded, rando11
A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation11
Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis11
Treatment strategy after noncurative endoscopic resection for early gastric cancers in patients aged ≥ 85 years: a multicenter retrospective study in a highly aged area of Japan11
Acknowledgements11
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data11
Comprehensive aptamer-based screen of 1317 proteins uncovers improved stool protein markers of colorectal cancer10
Definitive-dose adjuvant radiotherapy following endoscopic submucosal dissection for superficial esophageal cancer10
Correction: Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia10
Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis10
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-co10
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis10
Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease10
Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia10
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study10
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer10
Reply to: “COVID-19-associated liver injury (COVALI): role of hepatologists”10
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma10
Reply to “Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19”9
Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway9
Response to letter to the editor regarding: “Alcohol-associated liver disease increases the risk of muscle reduction and mortality in patients with cirrhosis”9
Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy9
Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection9
Activating KRAS and GNAS mutations in heterotopic submucosal glands of the stomach9
Estimating cancer risk in immune-mediated inflammatory diseases exposed to varying doses of tumour necrosis factor inhibitors9
The antiferroptotic effect of indigo on ulcerative colitis9
Multicenter prospective in vivo study of an endocytoscope system (ECS) for superficial esophageal cancer9
Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer9
Current status of type 1 (IgG4-related) autoimmune pancreatitis8
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus8
Acknowledgements8
A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer8
FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma8
Development of a capsule endoscopy scoring system for the early diagnosis of small bowel Crohn’s disease8
Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis8
A proposed risk assessment score for gastrointestinal stromal tumors based on evaluation of 19,030 cases from the National Cancer Database8
The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer8
Cost-effectiveness analysis of nivolumab plus chemotherapy vs chemotherapy for patients with unresectable advanced or metastatic HER2-negative gastric or gastroesophageal junction or esophageal adenoc8
Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review8
Letter to "The potential of an artificial intelligence for diagnosing MRI images in rectal cancer: multicenter collaborative trial"8
Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study8
0.22651600837708